Highlights and Quick Summary
- EPS Growth (diluted) for the quarter ending June 30, 2022 was -87.64% (a -78.58% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (diluted) decreased by -713.3%
- Annual EPS Growth (diluted) for 2021 was 90.59% (a -63.37% decrease from previous year)
- Annual EPS Growth (diluted) for 2021 was 247.28% (a -305.06% decrease from previous year)
- Annual EPS Growth (diluted) for 2020 was -120.59% (a -527.32% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (diluted) of Biofrontera AG Sponsored ADR
Most recent EPS Growth (diluted)of BFAGY including historical data for past 10 years.Interactive Chart of EPS Growth (diluted) of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | -87.64% | -409.09% | – |
| 2021 | 4378.54% | 14.29% | 0.0% | 29.03% | 90.59% |
| 2020 | 78.01% | 52.54% | 100.0% | -34.78% | -120.59% |
| 2019 | – | 62.57% | -210.53% | 41.67% | -95.76% |
| 2018 | – | – | – | 25.81% | -95.02% |
| 2017 | – | – | -167.14% | 67.8% | -119.24% |
| 2016 | -71.43% | – | – | – | -123.03% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic